The roles of natriuretic peptides in pericardial fluid in patients with heart failure
- PMID: 19301292
- PMCID: PMC6653017
- DOI: 10.1002/clc.20306
The roles of natriuretic peptides in pericardial fluid in patients with heart failure
Abstract
Background: It is well known that the plasma concentrations of atrial and brain natriuretic peptides, as cardiac hormones, are elevated in heart failure.
Hypothesis: Pericardial fluid in patients with various heart diseases contains both natriuretic peptides that are released into the pericardial fluid. However, it is unknown whether these peptides reflect cardiac function in patients with various heart diseases, more than both the peptides in blood.
Methods: Plasma and pericardial fluid samples were obtained from 22 patients undergoing cardiac surgery for the measurement of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) levels in plasma and pericardial fluid.
Results: The ANP levels in pericardial fluid were higher in patients with impaired left ventricular systolic function (ejection fraction<50% versus>or=50%; 77.0+/-4.9 versus 14.0+/-50.9, p=0.017), but not BNP.However, BNP levels in pericardial fluid were significantly higher in patients with left ventricle dilatation (left ventricular diastolic dimension<or=54 mm versus>54 mm; 130.3+/-68.9: 709.7+/-324.7, p=0.0168). Moreover, BNP levels in pericardial fluid were significantly higher in Grade III than Grade II and I (Grade I: echo-free space<5 mm, Grade II: 5-10 mm, Grade III: >10 mm).
Conclusion: These results suggest that BNP levels in pericardial fluid served as more sensitive and accurate indicators of left ventricular diastolic dysfunction, and that increased BNP levels in pericardial fluid may have an important pathophysiologic role in heart failure as a cardiocyte-derived antifibrotic factor.
Copyright (c) 2009 Wiley Periodicals, Inc.
References
-
- Moe GW, Grima EA, Wong NM, Howard RJ, Armstrong PW: Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. J Am Coll Cardiol 1996; 27: 720–727. - PubMed
-
- Yoshimura M, Yasue H, Ogawa H: Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure. Can J Physiol Pharmacol 2001; 79: 730–735. - PubMed
-
- Mebazaa A, Wetzel RC, Dodd‐o JM, Redmond EM, Shah AM, et al.: Potential paracrine role of the pericardium in the regulation of cardiac function. Cardiovasc Res 1998; 40: 332–342. - PubMed
-
- Klemola R, Tikkanen I, Vuolteenaho O, Toivonen L, Laine M: Plasma and pericardial fluid natriuretic peptide levels in postinfarction ventricular dysfunction. Eur J Heart Fail 2001; 3(1): 21–26. - PubMed
-
- Raymond RJ, Hinderliter AL, Willis PW, Palph D, Caldwell EJ, et al.: Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. Am J Coll Cardiol 2002; 39: 1214–1219. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
